CN Stock MarketDetailed Quotes
688068 Beijing Hotgen Biotech Co.,Ltd
- 29.55
- -0.45-1.50%
Market Closed May 15 15:00 CST
2.73BMarket Cap-103321P/E (TTM)
30.00High29.40Low6.88KlotVolume29.91Open30.00Pre Close20.43MTurnover0.74%Turnover Ratio99.83P/E (Static)92.47MShares55.8852wk High0.83P/B2.73BFloat Cap23.6752wk Low36.00Limit Up92.47MShs Float161.49Historical High24.00Limit Down2.00%Amplitude18.78Historical Low--Dividend TTM29.69Avg Price4.22KlotAsk--Div YieldTTM100Lot Size2.69KlotBid
Beijing Hotgen Biotech Co.,Ltd Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -31.21%104.7M | -82.09%598.96M | -86.59%370.39M | -85.15%287.77M | -85.55%152.19M | -40.89%3.34B | -27.46%2.76B | -46.42%1.94B | -35.87%1.05B | 951.07%5.66B |
| Refunds of taxes and levies | -99.54%22.7K | 26,472.12%34.83M | -67.20%4.94M | -72.32%3.95M | -64.26%4.94M | -58.42%131.06K | 102.57%15.06M | 661.69%14.26M | 694.41%13.83M | -96.10%315.24K |
| Cash received relating to other operating activities | 146.10%15.57M | 104.40%102.74M | 171.19%62.2M | 292.23%52.04M | -23.45%6.33M | 72.53%50.27M | -14.90%22.94M | -24.87%13.27M | -20.58%8.26M | 235.19%29.13M |
| Cash inflows from operating activities | -26.41%120.29M | -78.31%736.53M | -84.37%437.54M | -82.51%343.76M | -84.80%163.46M | -40.31%3.4B | -27.12%2.8B | -45.95%1.97B | -35.00%1.08B | 924.61%5.69B |
| Goods services cash paid | -61.46%60.89M | -79.31%224.6M | -65.41%318.54M | -71.01%226.22M | -70.26%158.02M | -36.43%1.09B | -46.84%920.92M | -51.93%780.27M | 11.30%531.27M | 786.45%1.71B |
| Staff behalf paid | -68.11%51.66M | -49.20%371.27M | -49.35%287.75M | -35.86%231.1M | -28.82%162.01M | -9.57%730.91M | 206.83%568.09M | 157.64%360.34M | 329.19%227.6M | 590.37%808.23M |
| All taxes paid | -77.41%7.15M | -85.32%54.61M | -92.92%24.84M | -92.55%19.54M | -78.01%31.65M | 18.77%371.95M | 13.89%350.68M | 83.38%262.23M | 777.15%143.93M | 3,480.34%313.18M |
| Cash paid relating to other operating activities | -73.26%14.59M | -39.50%137.99M | -37.14%157.75M | -38.98%66.42M | -51.66%54.58M | 6.11%228.1M | -5.03%250.94M | -26.91%108.85M | 46.44%112.89M | 198.10%214.96M |
| Adjustment items of operating cash outflws | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | -66.94%134.29M | -67.37%788.48M | -62.27%788.88M | -64.06%543.28M | -60.00%406.24M | -20.61%2.42B | -16.03%2.09B | -26.44%1.51B | 62.80%1.02B | 679.37%3.04B |
| Net cash flows from operating activities | 94.23%-14.01M | -105.31%-51.95M | -149.56%-351.35M | -143.94%-199.52M | -506.75%-242.78M | -62.99%978.75M | -47.55%708.98M | -71.30%454.03M | -94.21%59.69M | 1,506.38%2.64B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -68.50%186.12M | -48.25%1.06B | -57.95%934.73M | -56.54%807M | -21.96%590.84M | -41.92%2.06B | -9.19%2.22B | 98.19%1.86B | 162.88%757.1M | 109.50%3.54B |
| Cash received from returns on investments | -72.65%4.56M | 55.52%26.56M | -41.77%21.07M | -73.13%8.6M | 133.20%16.69M | -23.55%17.08M | 219.55%36.19M | 796.23%32M | 493.86%7.16M | 174.92%22.34M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 545.44%3.74M | ---- | ---- | ---- | 334.42%579.74K | 878.06%815.9K | 551.72%543.66K | ---- | 196.56%133.45K |
| Cash received relating to other investing activities | ---- | ---- | --10.34M | ---- | --303.83K | --20M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -68.63%190.69M | -47.73%1.1B | -57.25%966.15M | -56.84%815.6M | -20.47%607.83M | -41.23%2.1B | -8.11%2.26B | 100.88%1.89B | 164.26%764.25M | 109.82%3.57B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -68.10%40.5M | -26.87%413.36M | -29.71%228.86M | 24.49%277.81M | 53.46%126.98M | 41.71%565.21M | 49.48%325.6M | 43.74%223.16M | 83.85%82.74M | 131.53%398.86M |
| Cash paid to acquire investments | -80.00%86.9M | -68.94%826.17M | -75.27%691.29M | -77.85%508.29M | -65.24%434.53M | -45.82%2.66B | -21.49%2.8B | 5.92%2.29B | 50.27%1.25B | 190.31%4.91B |
| Cash paid relating to other investing activities | --15.43K | 21,660.58%17.42M | --17.42M | --17.42M | ---- | -99.60%80.06K | ---- | ---- | ---- | --20M |
| Cash outflows from investing activities | -77.31%127.42M | -61.03%1.26B | -69.96%937.58M | -68.08%803.52M | -57.88%561.51M | -39.47%3.23B | -17.39%3.12B | 8.45%2.52B | 51.99%1.33B | 185.95%5.33B |
| Net cash flows from investing activities | 36.58%63.27M | 85.68%-161.87M | 103.32%28.57M | 101.92%12.08M | 108.14%46.32M | 35.90%-1.13B | 34.72%-860.66M | 54.53%-627.82M | 3.24%-568.74M | -974.29%-1.76B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --1M | -14.18%7.14M | -50.78%3.8M | 138.01%7.14M | ---- | -13.60%8.32M | 672.00%7.72M | --3M | ---- | 863.00%9.63M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | -54.33%3.8M | -50.78%3.8M | ---- | ---- | -13.60%8.32M | 672.00%7.72M | ---- | ---- | 863.00%9.63M |
| Cash received relating to other financing activities | ---- | ---- | --3.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | --1M | -14.18%7.14M | -7.51%7.14M | 138.01%7.14M | ---- | -13.60%8.32M | 672.00%7.72M | --3M | ---- | 863.00%9.63M |
| Dividend interest payment | ---- | ---- | ---- | ---- | ---- | 233.33%310.98M | 233.57%311.2M | 233.33%310.98M | ---- | 388.33%93.29M |
| Cash payments relating to other financing activities | 1,256.66%87.96M | -76.04%43.69M | -84.53%16.44M | 164.25%16.96M | --6.48M | 1,498.77%182.33M | 1,164.68%106.3M | 13,171.31%6.42M | ---- | 3,606.62%11.4M |
| Cash outflows from financing activities | 1,256.66%87.96M | -91.14%43.69M | -96.06%16.44M | -94.66%16.96M | --6.48M | 371.17%493.31M | 310.52%417.5M | 240.04%317.4M | ---- | 142.57%104.7M |
| Net cash flows from financing activities | -1,241.23%-86.96M | 92.46%-36.55M | 97.73%-9.3M | 96.88%-9.82M | ---6.48M | -410.14%-484.99M | -306.93%-409.78M | -236.82%-314.4M | ---- | -125.48%-95.07M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 93.91%-78.21K | -108.94%-464.8K | -24.65%2.97M | 78.91%-366.54K | -137.03%-1.29M | 135.05%5.2M | 157.54%3.94M | 72.46%-1.74M | -2,327.87%-542.18K | -1,157.48%-14.83M |
| Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | --0.01 | ---- |
| Net increase in cash and cash equivalents | 81.50%-37.78M | 60.25%-250.83M | 40.97%-329.11M | 59.66%-197.62M | 59.92%-204.23M | -181.78%-631.09M | -746.47%-557.52M | -582.46%-489.93M | -215.06%-509.6M | 2,018.01%771.69M |
| Add:Begin period cash and cash equivalents | -47.94%272.39M | -54.67%523.21M | -54.67%523.21M | -54.67%523.21M | -54.67%523.21M | 201.69%1.15B | 201.69%1.15B | 201.69%1.15B | 201.68%1.15B | -9.51%382.61M |
| End period cash equivalent | -26.45%234.61M | -47.94%272.39M | -67.47%194.1M | -50.99%325.6M | -50.52%318.98M | -54.67%523.21M | 88.41%596.78M | 37.22%664.37M | -21.90%644.71M | 201.69%1.15B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg